{
  "paper_metadata": {
    "pmid": "34907500",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses variants in the TTR gene associated with transthyretin cardiac amyloidosis, specifically detailing the Val30Met and Leu58Arg mutations."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.148G>A",
      "protein_notation": "p.Val50Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 9,
        "demographics": "Mean age 73.2 \u00b1 13.0 years, 57% male",
        "phenotype": "ATTRv-CA (hereditary transthyretin cardiac amyloidosis)"
      },
      "penetrance_data": {
        "total_carriers_observed": 9,
        "affected_count": 9,
        "unaffected_count": 0,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ATTRv-CA",
          "evidence_sentence": "Among patients diagnosed with ATTRv-CA, 8 (89%) patients had Val30Met [p.V50M] mutation."
        }
      ],
      "functional_data": {
        "summary": "The Val30Met mutation is known to be associated with a high penetrance of ATTRv-CA.",
        "assays": []
      },
      "segregation_data": "The Val30Met mutation segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The Val30Met mutation is one of the most common mutations associated with hereditary ATTR.",
      "key_quotes": [
        "Among patients diagnosed with ATTRv-CA, 8 (89%) patients had Val30Met [p.V50M] mutation."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.173T>C",
      "protein_notation": "p.Leu58Arg",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Mean age 73.2 \u00b1 13.0 years, 57% male",
        "phenotype": "ATTRv-CA (hereditary transthyretin cardiac amyloidosis)"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ATTRv-CA",
          "evidence_sentence": "1 (11%) patient had Leu58Arg [p.L78A] mutation."
        }
      ],
      "functional_data": {
        "summary": "The Leu58Arg mutation is associated with a lower penetrance compared to Val30Met.",
        "assays": []
      },
      "segregation_data": "The Leu58Arg mutation has been observed in families with ATTRv-CA.",
      "population_frequency": null,
      "evidence_level": "medium",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The clinical significance of the Leu58Arg mutation is still being evaluated.",
      "key_quotes": [
        "1 (11%) patient had Leu58Arg [p.L78A] mutation."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Population characteristics",
      "variants_extracted": 2
    },
    {
      "table_name": "Table 2",
      "table_caption": "Quantitative 99mTechnetium-pyrophosphate uptake metrics",
      "variants_extracted": 0
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding TTR variants were successfully extracted."
  }
}